Filtered By:
Condition: Ischemic Stroke
Countries: Malaysia Health
This page shows you your search results in order of date.
Order by Relevance | Date
Total 48 results found since Jan 2013.
Association of underlying untreated cardiovascular risk factors with mortality and functional outcome in ischaemic stroke patients
Stroke is the third leading cause of death after ischaemic heart disease (IHD) and pneumonia in Malaysia.1 Aziz et al. reported that Malaysia's prevalence of ischaemic stroke had increased from 42.8 to 118.7 in 100,000 from 2010 to 2014. The report showed that 8-11% of ischaemic stroke patients died within 30 days while 56-61% survived with significant disability in Malaysia.2 Our previous study showed that patients with ischaemic stroke in Malaysia were younger, but the mortality rate was higher than in other countries.
Source: Journal of Stroke and Cerebrovascular Diseases - July 19, 2023 Category: Neurology Authors: Teck Long King, Lee Len Tiong, Zariah Abdul Aziz, Wan Chung Law Source Type: research
Survivability of patients admitted for stroke in a primary stroke center, Penang, Malaysia: a retrospective 5-year study
CONCLUSION: The findings of the study are intended to encourage more non-stroke hospitals in Malaysia to increase their efforts in treating stroke patients, as early treatment can help reduce the severity of the stroke. With the incorporation of evidence-based data, this study also contributes to local data for comparison and improves the implementation of regularly prescribed stroke medication.PMID:37131240 | PMC:PMC10152713 | DOI:10.1186/s40360-023-00669-8
Source: BMC Pharmacology and Toxicology - May 2, 2023 Category: Drugs & Pharmacology Authors: Monica Danial Nurul Shahira Izwani Mohdradzi Amer Hayat Khan Alan Swee Hock Ch'ng Looi Irene Source Type: research
Predictive model of recurrent ischemic stroke: model development from real-world data
ConclusionThe hazard of recurrent IS magnitude differs during different time intervals based on the concomitant risk factors and secondary prevention.
Source: Frontiers in Neurology - April 28, 2023 Category: Neurology Source Type: research
Stroke thrombolysis in a middle-income country: A case study exploring the determinants of its implementation
ConclusionsDespite the ongoing challenges, the success in implementing intravenous stroke thrombolysis as standard of care was attributed to the cohesiveness of team members and having facilitative work processes. For countries of similar settings, plans to improve the uptake of intravenous stroke thrombolysis should consider the inclusion of interventions targeting on these modifiable factors.
Source: Frontiers in Neurology - November 24, 2022 Category: Neurology Source Type: research
COVID-19 Can Increase Risk of Psychiatric Disorders for Up to Two Years
The increased risk of depression and anxiety that patients experience after developing COVID-19 typically subsides within two months, according to astudy published yesterday inThe Lancet Psychiatry. However, patients may have an elevated risk for developing other psychiatric and neurological conditions, such as psychosis, brain fog, and seizures, for up to two years after their infections.“The results have important implications for patients and health services as it suggests new cases of neurological conditions linked to COVID-19 infection are likely to occur for a considerable time after the pandemic has subsided,” s...
Source: Psychiatr News - August 18, 2022 Category: Psychiatry Tags: adults anxiety brain fog children COVID-19 delta dementia depression older adults omicron psychotic disorder seizures The Lancet Psychiatry Source Type: research
The outcomes of reperfusion therapy with streptokinase versus tenecteplase in ST-elevation myocardial infarction (STEMI): a propensity-matched retrospective analysis in an Asian population
Conclusion Streptokinase and tenecteplase are fibrinolytic agents with similar efficacy and safety in STEMI reperfusion therapy in our Asian population.
Source: International Journal of Clinical Pharmacy - March 3, 2022 Category: Drugs & Pharmacology Source Type: research
Case –Control Study and Meta-Analysis of the Association Between LIPG rs9958947 SNP and Stroke Risk
AbstractThe rs9958947 single nucleotide polymorphism (SNP) resides in the promoter region of the lipase G (LIPG) gene. This newly discovered SNP increases the risk of stroke in some Asian populations, including Chinese and Korean populations. Stroke is one of the top 5 leading causes of death in Malaysia, so it is of interest to investigate whether this SNP is associated with stroke risk in the Malaysian population. Therefore, this study investigates this association through a case –control study on a Malaysian population along with a comprehensive meta-analysis. Genotyping ofLIPG rs9958947 SNP was performed for 241 Mala...
Source: Journal of Molecular Neuroscience - October 1, 2021 Category: Neuroscience Source Type: research
SLC17A3 rs9379800 and Ischemic Stroke Susceptibility at the Northern Region of Malaysia
The relationships of Paired Like Homeodomain 2 (PITX2), Ninjurin 2 (NINJ2), TWIST-Related Protein 1 (TWIST1), Ras Interacting Protein 1 (Rasip1), Solute Carrier Family 17 Member 3 (SLC17A3), Methylmalonyl Co-A Mutase (MUT) and Fer3 Like BHLH Transcription Factor (FERD3L) polymorphisms and gene expression with ischemic stroke have yet to be determined in Malaysia. Hence, this study aimed to explore the associations of single nucleotide polymorphisms (SNPs) and gene expression with ischemic stroke risk among population who resided at the Northern region of Malaysia.
Source: Journal of Stroke and Cerebrovascular Diseases - August 10, 2021 Category: Neurology Authors: Shu Chai Ching, Lim Jing Wen, Nor Ismaliza Mohd Ismail, Irene Looi, Cheah Wee Kooi, Long Soo Peng, Lee Soon Mui, Jayashamani Tamibmaniam, Prema Muninathan, Ong Beng Hooi, Siti Maisarah Md Ali, Muhammad Radzi Abu Hassan, Mohd Saberi Mohamad, Lyn R Griffith Source Type: research
